For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Aptevo Research and Development LLC

USPTO Granted Patents = 12

CIPO Patents = 4

EPO Patents = 2

Trademarks = 3

Forward Citations = 36

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

John W Blankenship (7 out of 9 patents)

David Bienvenue (6 out of 7 patents)

Gabriela Hernandez-Hoyos (6 out of 7 patents)

4. Danielle Mitchell (6 out of 25 patents)

5. Catherine J McMahan (5 out of 5 patents)

6. Elaine Todd Sewell (5 out of 5 patents)

7. Philip Tan (4 out of 8 patents)

8. Peter Pavlik (4 out of 4 patents)

9. Peter Armstrong Thompson (3 out of 9 patents)

10. Lynda Misher (2 out of 8 patents)

11. Peter Ellmark (2 out of 17 patents)

12. Anna Sall (2 out of 5 patents)

13. Christina Furebring (2 out of 18 patents)

14. Laura Von Schantz (2 out of 11 patents)

15. Sara Fritzell (2 out of 9 patents)

12 patents: Sort by Forward Citations

1. 12441798 - CD123 binding proteins and related compositions and methods (2025-10-14),

2. 11939392 - CD123 binding proteins and related compositions and methods (2024-03-26),

3. 11352426 - CD3 binding polypeptides (2022-06-07),

4. 11312786 - Oncofetal antigen binding proteins and related compositions and methods (2022-04-26),

5. 11242400 - CD123 binding proteins and related compositions and methods (2022-02-08),

6. 10676533 - Methods of treatment of CD123 overexpressing disorders (2020-06-09),

7. 10307481 - CD37 immunotherapeutics and uses thereof (2019-06-04),

8. 10239949 - Oncofetal antigen binding proteins and related compositions and methods (2019-03-26),

9. 10202452 - CD3 binding polypeptides (2019-02-12),

10. 10143748 - B-cell reduction using CD37-specific and CD20-specific binding molecules (2018-12-04),

11. 9782478 - Prostate-specific membrane antigen binding proteins and related compositions and methods (2017-10-10),

12. 9493564 - CD86 antagonist multi-target binding proteins (2016-11-15),

Aptevo Research and Development LLC is a biotechnology company focused on discovering and developing novel cancer therapeutics. With a strong emphasis on research and innovation, Aptevo is committed to advancing groundbreaking treatments for patients in need. Visit their website to learn more about their cutting-edge research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

12 Patents

#153 in Seattle, WA

#545 in Washington

#24,782 in US

#46,701 in the World

Seattle, WA, United States of America

Aptevo Research and Development LLC

Forward Citations = 36

23 inventors:

John W Blankenship (7 out of 9 patents)

David Bienvenue (6 out of 7 patents)

Gabriela Hernandez-Hoyos (6 out of 7 patents)

4. Danielle Mitchell (6 out of 25 patents)

5. Catherine J McMahan (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…